Guest guest Posted November 29, 2006 Report Share Posted November 29, 2006 Sent: Saturday, December 28, 2002 11:30 AM Subject: "Silicone City" -- List of Chemicals in Implants Subject: Chemicals List CHEMICAL PROFILE for BREAST IMPLANTS 1. Methyl Ethyl Ketone 2. Cyclohexanone 3. Isopropyl alcohol 4. Denatured Alcohol 5. Acetone 6. Urethane 7. Polyvinyl Chloride (Liquid vinyl) This ingredient was used in all medical devices made at Lab, from tubing to gel. 8. Lacquer Thinner 9. Ethyl Acetate 10. Epoxy Resin 11. Epoxy Hardener - both 10 & 11 are chemically known as glycosides Ether of Bisphenol A. 12. Amine 13. Printing Ink 14. Toluene 15. Dichloromethan (Methylene Chloride) This breaks down in the body so blood cannot carry oxygen: Metabolizes carbon monoxide poisoning. Causes CSN depression. 16. Freon 17. Silicone 18. Flux 19. Solder 20. Metal cleaning Acid 21. Lofol (Formaldehyde) 22. Talcum Powder 23. Color Pigments as Release Agents 24. Oakite (Cleaning Solvent) 25. Eastman 910 glue (Cyanoacyrylates) 26. Ethylene Oxide (ETO) 27. Carbon Black 28. Xylene 29. Hexone 30. Hexanone2 31. Thixon-OSN-2 32. Antioxidant (Rubber) 33. Acid stearic 34. Zinc Oxide 35. Naptha (Rubber Solvent) 36. Phenol 37. Benzene - Known Carcinogen!!!!! KNOWN TO CAUSE IMMUNE DISEASE!!!!!! Abbreviations: ACGIH -American Conference of Governmental Industrial Hygienists ATSDR -Agency for Toxic Substances and Disease Registry CDC -Center for Disease Control IDLH -Immediately dangerous to life and health. Unless otherwise noted NIOSH IDLH data is used. EPA -Environmental Protection Agency LOAEL -Lowest observable adverse effects level MG/M3 -Milligrams per cubic meter MRL -Minimal risk level (non-cancer) NAS -National Academy of Science NE -No evidence could be found for the existence of an IDLH NIOSH -National Institute for Occupational Safety and Health NOAEL -No observable adverse effects level NRC -National Research Council OSHA -Occupational Safety and Health Administration OTS -Office of Toxic Substances PEL -Permissible exposure level PP/S -Personal protective equipment and/or sanitary measures required for PEL exposure PPB -Part (s) per billion PPM -Part (s) per million REL -Recommended exposure level TLV -Threshold Value Limits TN -Trade Name UG/KG -Microgram per kilogram UG/DL -Microgram per deciliter Unknown -Lack of data Notice: This material may be protected by copyright law (title 17 U.S.code) No information on numbers 11, 12, 18, 22, 24, 25, 25, 30, 31, and 33 1. 2-BUTANONE: TN/synonyms: Ethyl ketone. MEK, Methyl acetone, Methyl ethyl ketone. OSHAP PEL: 200 ppm - 8 hr/day-40hr/wk - PP/S 590 mg/m3 - 8 hr/day-40hr/wk-PP/S 300 ppm - exposure not to exceed 15 min 885 mg/m3 - exposure not to exceed 15 min ATSDR MRL: 0.1 ppm - Ihalation, less than 15 days IDLH: 3,000 ppm symptoms: Eye, nasal, throat, and upper respiratory ittitation; Headaches; Weakness; Lightheadedness; Dizziness; Vomiting; Numbness of extremities; Muscle weakness; Nausea; Loss of coordination; Respiratory system effects; Temporary blindness; Fatigue; Nerve inflammation behind the eyes. Suspected of causing Developmental effects. End-point Targets: Central nervous system, Lungs. Potentiation: In combination with other solvents it becomes a very hazardous neurotoxin. Synergiatic effect; Off-gasses formaldehyde when burned Note: Research suggests that humans are more sensitive than other species tested. Classification: Organic solvent (Ketone compound). 2. CYCLOHEXANONE; TN/synonms: Cyclohexyl ketone, Pimelic ketone. PSHA PEL: 25 ppm - 8 hr/day-40hr/wk - PP/S 100mg/m3 - 8 hr/day-40hr/wk - PP/S IDLH: 5,000 ppm Symptoms; Eye and mucus membrane irritation, Headaches, Unconsciousness due to narcotic effects. Coma, Dermatitis Suspected of causing Birth defects; Reproductive effects; Developmental effects; Neonatal lethality; Tearing; Weight loss; Lethargy; Unexpanded fetal lungs at birth; Pulmonary damage, edema, and hemorraging; Intestinal congestion Incoordination; Tremors; Hypothermia. End-point Targets; Respiratory system, Eyes, Skin, Central nervous system Classification; Organic solvent (Ketone compound). Note: Neurotoxin. 3. ISOBUTYL ALCOHOL: TN/Synonyms: IBA, Isobutanal, Isopropylcarbinol, 2-Methyl-1-propanol. OSHA PEL: 50 ppm - 8hr/day040hr/wk - PP/S 150 mg/m3 - 8 hr/day-40hr/wk - PP/S IDLH: 8,000 ppm Symptoms; Eye, nasal, throat, and skin irritation; Cardiac arrhythmias and failure; Central nervous system depression; Chemical sensitivity; Coma: confusion; Cough; Cracking skin; Death; Delirium; Dermatitis; Diarrhea; Drowsiness; Gastrointestinal hemorrhages; Giddiness; Glucose in urine; Headaches; Impaired performance; Incoordination; Kidney damage; Labored or difficulty breathing; Liver damage; Muscle weakness; Nausea; Pulmonary edema; Respiratory failure; Vertigo; Vomiting. Suspected of causing Cancer. End-point Targets; Eyes, Skin, Respiratory system. 4. ALCOHOLS, DENATURED Acetaldehyde; n-Butyl alcohol; sec-Butyl alcohol; Crotonaldehyde; Ethanol; n-Hexane; Pyridine; 1,1,2,2,-Tetrachloroethane; and Zinc chloride. 5. ACETONE: TN/synonyms: Dimethyl ketone, Ketone propane, Propanone, 2-Propanone, beta- Ketopropane, Methyl ketone. NIOSH REL: 250 ppm - 10hr/day-40hr/wk 590 mg/m3 - 10hr/day-40hr/wk OSHA PEL: 750 - 8hr/day-40hr/wk - PP/S 1,800 mg/m3 - 8 hr/day-40hr/wk - PP/S 1,000 ppm - not to exceed 15 min 2,400 mg/m3 - not to exceed 15 min IDLH 1,000 ppm Symptoms; Eye, nasal, and throat irritation; Belligerence; Blood poisoning; Alcoholic psychosis; Boastfulness; Bronchitis; Circulatory failure; Cold, pale skin; Coma; Collapse; Conjunctivitis; Convulsions; Death; Defatting dermatitis; Dilated pupils; Dizziness; Double vision; Drowsiness; Emotional liability; Exhilaration; Flushed face; Gastritis; Gastroduodenitis; Headaches; Hearing loss; Heart rate over 100 beats per minute; Hypothermia; Impaired or absent tendon reflexes; Incontinence; Incoordination; Increased susceptibility to infection; Inflammation of airway, stomach, and duodenum; Liver injury; Loss of sensation; Low blood pressure; Nausea; Peripheral vascular collapse; Pharyngitis; Pneumonia; Profuse sweating; Rapid pulse; Remorse; Renal lesions; Respiratory failure; Restlessness; Sensory disturbances; Shock; Slowed reaction time; Slurred speech; Stupor; Talkativeness; Vertigo' Vomiting blood; Vomiting; Weakness. Suspected of causing Adverse spermatoginic effects, Low birth weight, Neonate lethality End-point Target: Respiratory system, Eyes, Skin. Classification; Organic solvent (Ketone compound), Polar volatile organic compounds. Note: Found in the blood and urine in diabetes and other metabolic disorders. Neurotoxin. 6. URETHANE: Aniline, Ethylenediamine, N-Ethylmorpholine, Hydrazine, and Methylene chloride. 7.VINYL CHLORIDE; TN/synonyms: Chloroethene, Chloroethylene, Ethylene monochloride, Monochlorethylene, VC, Vinyl chloride monomer, VCM, 1-Chloroethylene. NIOSH: Carcinogen at any exposure level. Reduce exposure to lowest reliably detectable concentration. OSHA PEL: 1 ppm - 8hr/day-40hr/wk 5ppm - Ceiling limit, 15 min exposure ATSDR MRL: 0.006 ppm - Inhalation, more than 14 days ACGIH: Confirmed human carcinogen. IDLH: NIOSH - Carcinogen Symptoms: Pulmonary and kidney irritation; Abdominal pains; Abnormal chest x-rays; Abnormal decrease in blood platelets; Acroosteolysis (dissolution of the finger tips); Autoimmune responses similar to sclerosis; Benign uterine growths; Binds to IgG protein; Blockage of blood vessels; Cancer (central nervous system, respiratory tract, lymphatic and blood); Cyanosis of extremities; Death; Decreased libido; Decreased respiratory function; Discomfort upon exposure to dold; Dizziness; Drowsiness; Emphysema; Euphoria; Gastrointestinal bleeding; Headaches; Impotency; Inhibits blood clotting; Joint and muscle pain; Liver damage and enlargement; Loss of consciousness; Menstrual disturbances; Nausea; Numbness; Ovarian dysfunction, Pallor; Peripheral neurophthy; Pregnant toxemia, Prolapsed genital organs; Pulmonary fibrosis; Raynaud's phenomenon symptoms (aka Vinyl chloride disease); Scleroderma-like skin changes; Systemic sclerosis; Scleroderma; Spontanious abortions Stiff hands; Thickening of blood vessel walls and skin; Weakness; Autoimmune disease. Suspected of causing Birth defects, Testicular damage. End-point Targets: Liver, Central nervous system, Blood Lymphatic system. Additives/Contaminants: Stabilized with inhibitors such as phenol. Note; Occupational exposure of males has been associated with increased rates of spontaneous abortions in their spouses. Neurotoxin. 8. LACQUER THINNERS sec-Butyl acetate, Cumene, and Isobutyl acetate. 9. ETHYL ACETATE: TN/synonyms: Acetic ester, Acetic ether, Ethyl ester of acetic acid, Ethyl ethanoate. OSHA PEL: 400 ppm - 8hr/day-40her/wk - PP/S 1,400 mg/m3 - 8hr/day-40hr/wk - PP/S IDLH: 10,000ppm Symptoms: Eye, nasal, throat, and respiratory irritation; Belligerence; Boastfulness; Cold, painful skin; Coma; Convulsions; Corneal abnormalities; Death; Dermatitis; Dilated pupils; Double vision; Drowsiness; Emotional instability; Exhilaration; Flushed face; Gastritis; Headaches; Heart rate over 100 beats per minute; Hypoglycemia; Hypothermaia; Impaired motor skills; Impaaired or absent tendon reflexes; Incontinence; Incoordination; Low blood pressure; Lung, liver, kidney, and heart damage; Nausea; Partial or complete loss of sensation; Peripheral vascular reaction time; Slowed respiration; Slurred speech; Stupor; Talkativeness; Unconsciousness due to narcotic effects; Vertigo; Vomiting; Weakness. Suspected of causing Central nervous system depression, Death. End-point Targets: eyes, skin, Respiratory system. Classificaton; Polar volatile organic compounds. Note: neurotoxin. 10. EPOXY RESINS: Diglycidyl ether, Phthalic anhydride, Triethylamine, and Trimellitic anhydride. 13. PRINTING INKS: Acetone; Aniline; Benzidine; 2-Butanone; alpha-Chloroacetophenone; Cyclohexanone; diisobutyl ketone; Dimethylformamide; Ethyl acetate; Ethyl butyl ketone; Ethylene glycol; n-Heptane; Isoamyl acetate; Isopropyl acetate; Methyl n-amyl ketone; Methyl cellosolve; 5-Methyl-3-heptanone; 2-Nitropropane; 2-Pentanone; n-diisocyanate; 1/1/1/-Trichloroethane; Triethylamine; and Trimellitic anhydride. 14. TOLUENE: TN/synonyms: Methyl benzene, Methyl benzol, Phenyl methane, Toluol. OSHA PEL: 100 ppm - 8 hr/day-40hr/wk - PP/S 375 mg/m3 8 hr/day-40hr/wk - PP/S 150 ppm - exposure not to exceed 15 min 560 mg/m3 exposure not to exceed 15 min ATSDR MRL: 4 ppm - Inhalation, less than 15 days 1 ppm - Inhalation, more than 14 days IDLH: 2,000 ppm Symptoms Eye, skin, and respiratory irritation; Abdominal pain; Anemia: Birth defects; Central nervous system dysfunction and depression: Coma: Confusion: Death: Delerium: Dermatitis: Dilated pupils: Dizziness: Drowsiness: Dry skin: Emotional instability; Enlarged liver; Euphoria; Fatigue: Fetal anomalies and developmental delay: Fetal central nervous system dysfunction; Hallucinations: Headaches: impaired reaction time, perception, and motor control; Incoordination: Insomnia; Liver desorders and injury; Mild to severe toxic brain dysfunction; Muscle fatigue; Nausea; Nervousness; Neurobehavioral changes; Numbness, tingling, or prickling sensation; Organic affective syndrome; Psychosis; Tearing, Vertigo; Vision disturbances; Vomiting; Weakness. Suspected of causing Blurred vision, Involuntary eye movement, Tremors, Staggering gait, Abnormal electroencephalogram. End-point Targets: Central nervous system, Liver, Skin. Classification: Organic solvent, Polar volatile organic compounds. Note: Historically established as a neurotoxin. 15. METHYLENE CHLORIDE: TN/synonyms: Dichloromethane, Methylene dichloride, Narkotil 9tn), Salaesthin (tn), Solmethine (tn). NIOSH: Carcinogen at any exposure level. Reduce exposure to lowest possible level OSHA PEL: 500 ppm - 8hr/day-40hr/wk - PP/S 1000 ppm - ceiling limit 2000 ppm - 5 min max peak in any 2 hrs ACGIH: Suspected human carcinogen. ACGIH TLV: 50 ppm - 8hr/day-40hr/wk 175 mg/m3 - 8 hr/day-40hr/wk ATSDR MRL: 1.0 ppm - Inhalation, less than 15 days. 0.4 ppm - Inhalation, more than 14 days. IDLH: 5,000ppm Symptoms: Eye, nasal, throat, skin irritation; Fatigue; Weakness; Sleepiness; Lightheadedness; Dizziness: Reduced coordination; Limbs numb and/or tingling; Nausea; Death; Loss of consciousness; Liver and kidney damage; Increase in serum bilirubin; Partial or complete loss of sensation; Decrease in psychomotor skills and behavioral performance. Suspected of causing Cancer (lung), Low birth weight, Low sperm count, DNA damage, Genetic mutations, Chromosomal aberrations, Brain damage. End-point Targets; Skin, Cardiovascular system, Central nervous system. Note: Does not easily burn. Classification; Halogenated organic compountd, Polar volatile organic compounds. Note: neurotoxin 16. FREON: Carbon tetrachloride, Dichlorodifluoromethane, Dichloromonofluoromethane, Dichloromonofluoromethane, Dichlorotetrafluoroethane, Fluorotrichloromethane, Methyl chloride, and Trifluorobromomethane. 17. SILICONE Chlorobenzene; Cresols; Isophorone; Methyl chloride; Stibine; Tetrachloroethylene; Tin; 1,1,1,-Trichloroethane. 19. SOLDERING MATERIALS; Antimony, Arsine, Cadmium, Hydrazine, Lead, Silver, Tin, Triethylamine, and Zinc chloride. 20. METAL CLEANERS: 2-Butoxyethanol; Cyanides; Diacetone alcohol; Ethylene dichloride; Ethylene glycol; Hydrogen peroxide; Manganese; Methylene chloride; Naphtha; Oxalic acid; Petroleum distillates; Silver; 1,1,2,2,0Tetrachloroethane; and Tetrachloroethylene 21. FORMALDEHYDE: TN/sysnonyms: Quaternium - 15, Methanal, Methyl aldehyde, Methylene oxide, Formalin, Formaic aldehyde, Formalith, Formol, Fyde, BVF, Morbicid, Oxymethylene; Oxomethane, Lysoform, Lofol, superlysoform, Fannoform, Ivalon. NIOSH: Carcinogen at any exposure level NIOSH REL: 0.016 ppm - 10hr/day-40hr/wk 0.100 ppm - ceiling limit not to exceed 15 min OSHA PEL: 1.000 ppm - 8 hr/day-40hr/wk - PP/S 2.000 ppm - exposure not to exceed 15 min 0.500 ppm - requires medical surveillance NAS: There is no population threshol for irritation effects. NRC: Fewer than 20% but perhaps more than 10% of the general population may be suspectible to formaldehyde and may react acutely at any exposure level. ACGIH: Suspected human carcinogen. IDLH: 30 ppm Symptoms; Eye, nasal, throat, and pulmonary irritation; Acidosis; Acute sense of smell; Alters tissue proteins; Anemia; Antibodies formation; Apathy: Blindness; Blood in urine; Blurred vision; Body aches; Bronchial spasms; Bronchitis; Burns nasal and throat; Cardiac impairment, palpitations and arrhythmias; Central nervous system depression; Changes in higher cognitive functions; Chemical sensitivity; Chest pains and tightness; Chronic vaginitis; Colds; Coma; Conjunctivitis; Constipation; Convulsions; Corneal erosion; cough; Death; Destruction of red blood cells; Depression; Dermatitis; Diarrhea; Difficulty concentrating; Disorientation; Dizziness; DNA damage; Drowsiness Ear aches; Eczema; Emotional upsets; Ethmoid polypos; Fatigue; Fecal bleeding; Fetal asphyxiation; Flu-like or cold-like illness; Frequent urination with pain; Gastritis; Gastrointestinal inflammation; Headaches; Hemolytic anemia; Hemolytic hematuria; Hoarseness; Hyperactive airway disease; Hyperactivity; Hypomenstrual syndrome; Immune system sensitizer; Impaired (shsort) attention span; Impaired capacity to attain attention; Inability or difficulty swallowing; Inability to recall words and nae=mes; Intestinal pain; Intrinsic asthma; Irritaability; Jaundice; Joint pains,m aches, and swelling; Kidney pain; Larynbgeal spasm: Loss of memory; Loss of sense smell; Loss of taste: Malaise; Menstrual and testicular pain; Menstrual irregularities; Metallic taste; Muscle spasms and cramps: Nasal congestion, crusting, and mucosa inflammation; Nausea; Nosebleeds; Numbness and tingling of the forearms and finger tips: Pale, clammy skin: Partial laryngeal paralysis: Pneumonia: Post nasal drip: Pulmonary edema; Reduced body temperature: Retarded speech pattern: Ringing or tingling in the ear: Schizophrenic-type symptoms; Sensitivity to sound; Shock; Short term memory loss; Shortness of breath: Skin lesions; Sneezing; Sore throat: Spacey feeling; Speaking difficulty: Sterility: Swollen glands; Tearing: thirst: Tracheitis: Tracheobronchitis: Vertigo: Vomiting blood: Vomiting: Wheezing. Suspected of causing Cancer, Genetic mutations, Chromosomal damage. End-point Targets: Respiratory system, Eyes, Skin, Central nervous system, Liver, Kidneys, Gastrointestinal tract, Cardiovascular system. Metabolized as Formic acid. Note: Will cross sensitize to formic acid. Comparison of ciliostatic effects showed formaldehyde to be the most toxic of the aldehydes. EPA estimates that 15 people in 1 million will get cancer from lifetime exposure of 1 ppb. Neurotoxin. 23. PIGMENTS Aniline, Antimony trioxide, Arsenic, barium, Benzidine, Cadmium, Carbon monoxide, Chromium, Cobalt, Cyanides, Diacetone alcohol, Dibutylphthalate, Dimethylformamide, Ethyl acrylate, Lead, Mercury, Methyl cellosolve, Molybdenum, Nickel, p-Nitroaniline, Nitrophenols, Oxalic acid, Phthalic anhydride, Selenium, Tellurium Titanium dioxide, Tributyl phosphate, Trimellitic anhydride, Vanadium pentoxide, and Zinc oxide. 26. ETHYLENE OXIDE: TN?synonyms: Dimethylene oxide; 1,2-Epoxy ethane: Oxirane: Dihydro-oxirene; Epoxyethane; Ethene oxide; ETP Anprolene (tn)/ Oxyfune (tn); T-Gas (tn). NIOSH: Carcinogen at any exposure level. NIOSH REL:< 0.1ppm - 10hr/day-40hr/wk 0.18 mg/m3 - 10hr/day-40hr/wk 5 ppm - cdeiling limit 9 mg/m3 - 15 min/day OSHA PEL: 1 ppm - 8hr/day-40hr/wk 5ppm - 15-min Excursion ACGIH: Suspected human carcinogen. ATSDR MRL: 0.09 ppm - Inhalation, more than 14 days IDLH: 800 ppm Symptoms: Eye, nasal and throat irritation; Bronchitis; Burns skin and eyes; Cancer (Leukemia, stomach, pancreatic): Cataracts: Chromosomal aberrations; Cornieal burns; Cyanosis; Decreased sperm coundt; Diarrhea; Electrcardiogram abnormalities; Emphysema; Frostbite; Headaches; Hodgkin's disease; Impaired hand/eye coordination; Labored or difficulty breathing; Memory loss; Nausea; Neuropathy; Numbness, tingling, or prickling sensation; Peculiar taste; Peripheral neurophathy: Pulmonary edema; Spontaneous abortion; Vomiting. Suspected of causing Nasal mucosa inflammation, Epithelial tissue death, Respiratory lesions, Low birth weight, Neonate lethality, Birth defects, Testicular degeneration, Convulsions, Liver and kidney damage. End-point targets: Respiratory system, Central nervous system. 27. CARBON BLACK TN?sysonyms: Acetylene black, Channel black, Furnace black, Lamp black, Thermal black. NIOSH: Carcinogen AT ANY EXPOSURE LEVEL. OSHA PEL: 3.5 mg/m3 - 8 hr/day-40hr/wk Symptoms Unknown Target organ: Unknown Note: Present in Polycyclic aromatic hydrocarbons. 28. XYLENES: TN/synonyms: Dimethylbenzene, Eyolol, Methyl toluene, violet 3 (tn). Isomers: m-Xylene - 1,2-Dimethylbenezene; 1,3-Xylene; m-Dimethylbenzene: m-Xyolol: m-Methyltoluene; meta-Xylene. o-Xylene - 1,2-Dimethylbenezene: 1,2-Xylene; o-Dimethylbenzene; o-Xyolol; o-Methyltoluene; ortho-Xylene. p-Xylene - 1,4-"Dimethylbenezene: 1,4-Xylene; p-Dimethylbenzene; p-Xyolol; p-Methyltoluene: para-Xylene; Scintillar (tn) ASHA PEL: 100 ppm - 8 hr/day-40hr/wk - PP/S 435 mg/m3 8hr/day-40hr/wk - PP/S 150 ppm - exposure not to exceed 15 min 655 mg/m3 exposure not to exceed 15 min IDLH: 1,000 ppm Symptoms: Eye nasal, throat, and respiratory irritation; Abdominal pain; Abnormal electrocardiograms; Amnesia; Brain hemorrhage; Cardiac palpitations; confusion; Corneal vacuolization; Death; Dermatitis; Dizziness; Drowsiness; Epileptic convulsions; Excitement; Fatigue; Gastric discomfort; Headaches; Impaired ability to work with numbers, balance, pulmonary function, and reaction times; Labored breathing; Lightheadedness; Liver and kidney damage; Loss of appetite and patience; Nausea; Pulmonary congestion, hemorrhaging, edema and damage; Reduced coordination; Respiratory failure; Short-term memory loss; Staggering gait; Tremors; Unconsciousness due to narcotic effects; Ventricular fibrillation; Vomiting Suspected of causing Birth defects: Spontaneous abortions; Cerebral dysfunction; Blurred vision; Involuntary eye movement End-point Targets: Central nervous system, Eyes, blood, Skin, gastrointestinal tract, Liver, Kidneys. Mixed Xylenes usually contain the three forms of xylenes and 6% to 15% ethylbenzene. Classification: Organic solvent, Polar volatile organic compounds. Note: Neurotoxin. 29. Hexone: TN/synonyms: Isobutyl Methyl ketone, Methyl isobutyl ketone, 4-Methyl 2-pentanone, MIBK OSHA PEL: 50 ppm - 8hr/day-40herwk - PP/S 205 mg/m3 - 8hr/day-40hr/wk - PP/S 75 ppm - exposure not to exceed 15 min 300 mg/m3 - exposure not to exceed 15 min IDLH: 3,000 ppm Symptoms: Eye, nasal, throat and mucus membrane irritation; Headaches; Nausea; Vomiting; Loss of appetite; Diarrhea; Drowsiness: Dizziness: Loss of balance; Weakness: Stomach pain; Sore throat; Fatigue; Insomnia: intestinal pain: Enlarged liver; Colitis; Unconsciousness due to narcotic effects; Coma; Dermatitis: Central nervous system depression, Lightheadedness; Incoordination; somnolence; Heartburn; Central nervous system impairment. End-point Targets: Respiratory system, Eyes, Skin, Central nervous system. Note: Occupational tolerance seems to develop during the work week but is lost over the weekend. some adverse effects have been noted below ASHA PEL. Classification: Organic solvent (Ketone compound). 32. RUBBER Acetic acid; Acetone; Acetonitrile; Acrylonitrile; Aluminum; Ammonia; sec-Amyl acetate; Aniline; Antimony trioxide; Asbestos; Barium; Benzene; Benzyl chloride; 1,3-Butadiene; n-Butyl alcohol; Butylamine; Calcium oxide; Camphor; Carbon disulfide; Chlorinated diphenyl; Chlorobenzene; Chloroform; beta-Chloroprene; Chromium; Crotonaldehyde; Decaborane; Dibornane; o-Dichlorobenzene; 1,2-Dichloroethylene; Diethylamine; Diglycidyl ether; Dimethylamine Dimethylphthalate; Ethanolamine; Ethylene dichloride; N-Ethylmorpholine; Formaldehyde; Furfural; Hexachloroethane; Hydroquinone; Isopropylamine; Magnesium oxide; Mesityl oxide; Mica; Molybdenum; Morpholine; p-Nitrochlorobenzene; Nitrophenols; n-Nitrosodimethylamine; Oxalic acid; Paraldehyde; p-Phenylene diamine; Phthalic anhydride; Polychlorinated biphenyls; Propylene dichloride; Propylene imine; Pyridine; Quinone; Selenium; Styrene; Sulfur monochloride; Tellurium; 1,1,2,2-Tetrachloroethane; Tetrahydrofuran; Titanium dioxide; o-Toluidine; Toluene; 1,1,2-Trichloroethane; Triethylamine; Vanadium pentoxide; Xylenes' Zinc chloride; and Zinc oxide. 34. ZINC OXIDE: OSHA PEL: 5mg/m3 - 8hr/day - 40hr/wk 10mg/m3 - exposure not to exceed 15 min IDLH: NE Symptoms: Sweet or metallic taste, Dry throat, Cough, Chills, Fever, Tight chest, Labored or difficult breathing, Rales, Reduced pulmonary function, Blurred vision, Muscle cramps and pain, Lower back pain, Nausea, Vomiting, Fatigue, Lassitude, Malaise, Metal fume fever, Dermatitis, Boils, Conjunctivitis, Gastrointestinal disturbances, Pneumonia, Increase in leukocytes in the blood, Liver dysfunction, Gastrointestinal inflammation, Yawning, Weakness, Body aches, Headaches. End-point Targets: Respiratory system, Skin. Note: In one report, symptoms didn't appear until after 6 months of occupational exposure. 35. NAPTHA: TN/synonyms: Crude solvent coal tar naptha, High solvent naptha. OSHA PEL: 100 ppm - 8hr/day - 40hr/wk - PP/S 400 mg/m3 - 8hr/day - 40hr/wk - PP/S IDLH: 10,000 ppm Symptoms: Eye, nasal, throat, and skin irritation; Lightheadedness; Headaches; Loss of appetite; Dizziness; Indigestion; Nausea; Insomnia End-point Targets: Respiratory system, Eyes, Skin Component: Cumene Classification: Organic solvent (Refined Petroleum) 36. PHENOL TN/synonyms: Carbolic acid, Hydroxybenzene, Monohydroxy benzene, Phenyl alcohol, Phenyl hydroxide. NIOSH REL: 5 ppm - 10her/day - 40hr/wk 19 mg/m3 - 10hr/day - 40hr/wk 15.6ppm - ceiling limit, 15 min exposure 60 mg/m3 - ceiling limit, 15 min exposure OSHA PEL: 5 ppm - 8hr/day - 40hr/wk - PP/S 19 mg/m3 8hr/day - 40hr/wk - PP/S HSDB TOXS; Some individuals may be hypersensitive with lethality or serious effects at very low exposures IDLH: 250 ppm Symptoms: Eye, nasal and throat irritation; Abdominal pain; Cardiac arrhythmias and failure; Cardiovascular collapse; Chemical odor on breath; Chromosomal aberrations and damage; Cold sweats: Collapse: Coma: Confusion: Convulsions; Cyanosis; Dark pigmentation of the ligaments, cartilage, and fibrous tissue; Dark urine; Dermatitis; Diarrhea; Difficulty swallowing; Dizziness; Excessive bilirubin in blood; Excitement; Fainting; Frothing at nose and mouth; Genetic mutations; Granules in red blood cells; Headaches; Hemoglobin oxidizes to ferric form; Hemolytic anemia; Hypothermia; Liver, kidney, and heart damage; Loss of appetite; Low blood pressure Muscle aches, pain, and twitching; Nausea; Pallor; Profuse sweating; Pulmonaary edema; Renal infufficiency; Ringing or tingling in the ear; Shallow respiration; Shock; Skin burnns; Spontaneous abortions; Tremors; Unconsciousness; Vomiting: Weak, irregular pulse; Weakness; Weight loss. End-point Targets: Liver, Kidneys, Skin Derivative of Benzene. Note: historically established as a neurotoxin. 37. BENZENE TN/synonyms: Benzol, Benzole, Annulene, Benzeen Phenyl hydride, Coal naptha, Cyclohexatriene, Fenzen, Phene, Pyrobenzol, Pyrobenzole, Polystream (tn) Benzol 90 (tn). NIOSH: Carcinogen at any exposure level. NIOSH REL: 0/1 ppm - 10hr/day-40hr/wk 1 ppm - exposure not to exceed 15 min OSHA PEL: 1 ppm - 8hr/day - 40hr/wk - PP?S 5 ppm - exposure not to exceed 15 min ACGIH: Suspected human carcinogen. ATSDR MRL: .001 ppm - inhalation, less than 15 days. IDLH: 3,000 ppm Symptoms; Eye, nasal, and respiratory system irritation; Eye, skin, DNA, immune system, and chromosomal damage; Abnormal decrease in white blood cells; Anemia; Antibody formation, Aplastic anemia: Asphyxia; Blood diseases; Blurred vision; Bone marrow depression, Bronchitis; Cancer (leukemia); Cardiac collapse; Central nervous system depression; Cerebral swelling; Congestive gastritis; Convulsions; Death; Decreased antibodies, leukocytes, erythrocytes, and platelets; Decreased coordination; Delirium; Dermatitis; Dizziness; Drowsiness; Effects brain catecholamines; Euphoria; Fatigue; Gastritis; Giddiness; Granular tracheitis; Headaches; Impaired judgement; Kidney congestion; Laryngitis; Lassitude: Leukocyte chromosomal aberrations; Lightheadedness; Loss of appetite; Loss of balance; Menstral pain and disorders; Nausea; Nervousness; Non-lymphocytic leukemia; Ovarian atrophy; Pallor; Paralysis; Premature births; Pulmonary hemorrhage; Pyloric strictures; Underdevelopment of organs or body; Vertigo; Vomiting; Weakness. Suspected of causing Birth defects. End-point Targets: Blood, Central nervous system, bone marrow, Skin, Eyes, Respiratory system. Metabolites: Benzene oxide oxepin, Muconic acid, Phenyl Mercapturic acid, Pre-phenyl mercapturic acid, Benzene oxide, Benzene glycol, Muconaldehyde, Benzoquinone, Hydroquinone, Phenol, Catechol, Trihydroxy benzene, Glucuronide, Sulfate. Classification: Organic solvent. Note: Historically established as a neurotoxin. References. . . 4. Denatured alcohols, 6. Urethane, 8. Lacquer thinners, 10. Epoxy resin, 13. Printing inks, 16. Freon, 17. Silicone 19. Soldering materials, 20. Metal cleaners, 23. Pigments, and 32. Rubber. , C.: Chemical Exposure and Human Health: A Reference to 314 Chemicals, with a Guide to Symptoms, and a Directory of Organizations, (1993) McLFarland & Company, Jefferson, NC. 1. 2-Butanone:U.S. Department of Health and Human Services, Public Health Service,Centers for Disease Control, National Institute for Occupational Safety andHealth, "NIOSH Pocket Guide to Chemical Hazards," June 1990, U.S.Government Printing Office, Washington, D.C.U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, "Toxicology Profile for 2-Butanone," July 1992, Syracuse Research Corporation. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, "NIOSH Current Intelligence Bulletin 48 - Organic Solvent Neurotoxicity, "March 31, 1987. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, "Regulations, Recommendations and Assessments Extracted from RTECS: A Subfile of the Registry of Toxic Effects fof Chemical Substances, " September 1986, U.S. Government Printing Office U.S. Environmental Protection Agency, Air Quality Planning and Substances, "NATICH Data Base Report On State, Local, and EPA Air Toxics Activities," July 1990. U.S. Environmental Protection Agency, Office of Toxic Substances, Economic and Technology Division, "Toxics in the Community, National and Local Perspectives, The 1989 Toxics Release Inventory National Report," September 1991, Government Printing Office. 2. Cyclohexanone: Committee on Neurotoxicology and Models of Assessing Risk, Board on Environmental Studies and Toxicology, Commission of Life Sciences, National Research Council, "Environmental Neurotoxicity," 1992, National Academy Press, Washington, DC. U.S. Department of Health and Human Services, Public Health Service, Centers for Desease Control, National Institute for Occupational Safety and Health, "NIOSH Pocket Guide to Chemical Hazards," June 1990, U.S. Government Printing Office, Washington, D.C. U.S. Department of Health and Human Services, Public Health Services. Centers for Disease Control, National Institute for Occupational Safety and Health, Division of Standards Development and Technology Transfer, "Occupational Safety and Health Guidelines for Chemical Hazards," 1988, U.S. Government Printing Office Washington, D.C., Publications No. 89-104 U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, "NIOSH Current Intelligence bulletin 48 - Organic Solvent Neurotoxicity," March 31, 1987. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control. National Institute for Occupational Safety and Health, "Regulations, Recommendations and Assessments Extracted from RTECS: A Subfile of the Registry of Toxic Effects of Chemical Substances," September 1986. U.S. Government Printing Office. U.S. Environmental Protection Agency, "Cyclohexnone: Response to the Interagency Testing Committee," Federal Registry, January 3, 1984; 49 (1):136-142. U.S. Environmental Protection Agency, "Memorandum: Further Developmental Toxicity Testing on Cyclohexanone," May 4, 1988. U.S. Environmental Protection Agency, Air Quality Planning and Substances, "NATICH Data Base Report On State, Local, and EPA Air Toxics Activities," July 1990. U.S. Environmental Protection Agency, Office of Pesticides and Toxic Substances, "Memorandum: Request for Assistance on Cyclohexanone," August 23, 1984. U.S. Environmental Protection Agency, Office of Toxic Substances, RAB RM-1 Presentation For Cyclohexanone," November 15, 1990. U.S. Environmental Protection Agency, Office of Toxic Substances, "RM1 Meeting Summary: Cyclohexanone," November 15, 1990. 3. Isobutyl Alcohol: National Library of Medicine's Toxicology Information Program, Agency for Toxic Substances and Disease Registry, Hazardous Substances Data Bank, "2-Methyl-1-Pentanol," as of January 18, 1992. U.S. department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, "NIOSH Pocket Guide to Chemical Hazards," June 1990, U.S. Government Printing Office, Washington, D.C. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease control, National Institute for Occupational Safety and Health, "Regulations, Recommendations and Assessments Extracted from RTECS: A Subfile of the Registry of Toxic Effects of Chemical Substances," September 1986, U.S. Government Printing Office. U.S. Environmental Protection Agency, "TSCA Section 4 Profile of Isobutyl Alcohol," November 14, 1991. 5. Acetone: Committee On Neurotoxicology and Models of Assessing Risk, Board on Environmental Studies and Toxicology, Commission of Life Sciences, National Research Council, Environmental Neurotoxicity, 1992, National Academy Press, Washington, DC. National Library of Medicine's Toxicology Information Program, Agency for Toxic Substances and Disease Registry, Hazardous Substances Data Bank, "Acetone," as of January 13, 1992. , C.L., Editor, Taber's Cyclopedic Medical Dictionary, 16th Edition, 1989, F.A. Company, Philadelphia, PA. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, "NIOSH Pocket Guide to Chemical Hazards," June 1990, U.S. Government Printing Office, Washington, D.C. U.S. Department of Health and Human Services, Public Health Services, Centers for Disease Control, National Institute for Occupational Safety and Health, Division of Standards Development and Technology Transfer, "Occupational Safety and Health Guidelines for Chemical Hazards," 1988, U.S. Government Printing Office, Washington, D.C., Publication No. 89-104. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, "NIOSH Alert - Request for Assistance in Preventing Deaths of Farm Workers in Manure Pits," May 1990. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, "Regulations, Recommendations and Assessments Extracted from RTECS: A Subfile of the Registry of Toxic Effects of Chemical Substances," September 1986, U.S. Government Printing Office. U.S. Environmental Protection Agency, "TSCA Section 4 Profile of Acetone," November 14, 1991. U.S. Environmental Protection Agency, Air Quality Planning and Substances, "NATICH Data Base Report On State, Local, and EPA Air Toxics Activities," July 1990. 7. Vinyl chloride: Committee on Neurotoxicology and Models of Assessing Risk, Board on Environmental Studies and Toxicology, Commission of Life Sciences, National Research Council, Environmental Neurotoxicity, 1992, National Academy Press, Washington, DC. National Library of Medicine's Toxicology Information Program, Agency for Toxic Substances and Disease Registry, Hazardous Substances Data Bank, "Vinyl Chloride," as of January 24, 1992. U.S. Department of health and Human Services, Public Health Services, Centers for Disease Control, National Institute for Occupational Safety and Health, Division of Standards Development and Technology "Transfer, "Occupational Safety and Health guidelines for Chemical Hazards," 1988, U.S. Government Printing Office, Washington, D.C. Publication No. 88-118. U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, "Draft for Public Comment: Toxicology Profile for Vinyl Chloride," October 1991, Clement International Corporation. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, "NIOSH Pocket Guide to Chemical Hazards," June 1990, U.S. Government Printing Office, Washington, D.C. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease control, National Institute for Occupational Safety and Health. "Regulations, Recommendations and Assessments Extracted from RTECS: A Subfile of the Registry of Toxic Effects of Chemical Substances," September 1986, U.S. Government Printing Office. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, "NIOSH Current Intelligence bulletin 28 - Vinyl Halides Carcinogenicity: Vinyl bromide Vinyl Chloride, Vinylidene," September 21, 1978, U.S. Government Printing Office, Washington, DC. U.S. Environmental Protection Agency, Air quality Planning and Substances, "NATICH Data Base Report On State, Local, and EPA Air Toxics Activities," July 1990. U.S. General Accounting Office, "Reproductive and Developmental Toxicants: Regulatory Actions Provide Uncertain Protection," October 1991. (GAP/PEMD-92-3) 9. Ethyl Acetate: Committee on Neurotoxicology and Models of Assessing Risk, Board on Environmental studies and Toxicology, commission of Life Sciences, National Research Council, Environmental Neurotoxicity, 1992, National Academy Press, Washington, DC. National Library of Medicine's Toxicology Toxicology Information Program, Agency for Toxic Substances and Disease Registry, Hazardous Substances Data Bank, "Ethyl Acetate," as of January 16, 1992. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, "NIOSH Pocket Guide to Chemical Hazards," June 1990, U.S. Government Printing Office, Washington, D.C. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, "Regulations, Recommendations and Assessments Extracted from RTECS: A Subfile of the Registry of Toxic Effects of Chemical Substances," September 1986, U.S. Government Printing Office. 14. Toluene: Committee on Neurotoxicology and Models of Assessing Risk, Board on Environmental Studies and Toxicology, commission of Life Sciences, National Research Council, Environmental Neurotoxicity, 1992, National Academy Press, Washington, DC. National Library of Medicine's Toxicology Information Program, Agency for Toxic Substances and Disease Registry, Hazardous Substances Data Bank, "Methyl Isobutyl Ketone," as of January 18, 1992. New York Department of Law; Abrams, Attorney General, The Secret Hazards Of Pesticides, June 1991. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, "NIOSH Pocket Guide to Chemical Hazards," June 1990, U.S. Government Printing Office, Washington, D.C. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, "NIOSH Current Intelligence Bulletin 48 - Organic Solvent Neurotoxicity," March 31, 1987. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, "Regulations, Recommendations and Assessments Extracted from RTECSS: A Subfile of the Registry of Toxic Effects of Chemical Substances," September 1986, U.S. Government Printing Office. U.S. Department of Health and Human Services, Public Health Service, Center for Disease Control, National Institute for Disease Control, National Institute for Occupational Safety and Health, "Proposed National Strategies for the Prevention of Leading Work-Related Disease and Injuries: Neurotoxic Disorders," 1988, Government Printing Office, Washington, DC. U.S. Environmental Protection Agency, Air Quality Planning and Substances, "NATICH Data Base Report On State, Local, and EPA Air Toxics Activities," July 1990. U.S. Environmental Protection Agency, Office of Toxic Substances, Economic and Technology Division, "Toxics in the community, National and Local Perspectives, The 1989 Toxics Release Inventory National Report," September 1991, Government Printing Office. U.S. General Accounting Office, "Reproductive and Developmental Toxicants: Regulatory Actions Provide Uncertain Protection," October 1991. (GAO/PEMD-92-3) U.S. Public Health Service, Agency for Toxic Substances and Disease Registry, U.S. Environmental Protection Agency, "Toxicological Profile For Toluene," December 1989. 15. Methylene Chloride: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, "NIOSH Pocket guide to Chemical Hazards," June 1990, U.S. Government Printing Office, Washington, D.C. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, "NIOSH Current Intelligence bulletin 43 - Monohalomethanes: Methyl Chloride, Methyl Bromide, Methyl Iodide," September 27, 1984. U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, "Toxicology Profile for Chloromethane," December 1990, Syracuse Research Corporation. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, "NIOSH Current Intelligence Bulletin 48 - Organic Solvent Neurotoxicity," March 31, 1987. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health. "Regulations, Recommedations and Assessments Extracted from RTECS: A Subfile of the Registry of Toxic Effects of Chemical Substances," September 1986, U.S. Government Printing Office. U.S. Department of Health and Human Services, Public Health Service, Center for Disease Control, National Institute for Occupational Safety and Health, "Proposed National Strategies for the Prevention of Leading Work-Related Disease and Injuries: Neurotoxic Disorders," 1988, government Printing Office, Washington, DC. U.S. Environmental Protection Agency, Air Quality Planning and Substances, "NATICH Data Base Report On State, Local, and EPA Air Toxics Activities," July 1990. 21. Formaldehyde: Committee on Neurotoxicology and Models of Assessing Risk, Board on Environmental Studies and Toxicology, commission of Life Sciences, National Research Council, Environmental Neurotoxicity, 1992, National Academy Press, Washington, DC National Library of Medicine's Toxicology Information Program, Agency for Toxic Substances and Disease Registry, Hazardous Substances Data Bank, "Formaldehyde," as of January 17, 1992. National Research Council, Assembly of Life Sciences, committee on Aldehydes, Based in Toxicology and Environmental Health Hazards, Formaldehyde and Other Aldehydes, 1981, National Academy Press, Washington, DC. New Jersey Department of Health, "Hazardous Substance Fact Sheet "Formaldehyde'," 1986. Swanson, J.R., Formaldehyde: The Psychological and Educational Implications of Formaldehyde Toxicology, 1984, college of Education, University of Washington, Seattle, Wa. , C.L., Editor, Taber's Cyclopedic Medical Dictionary, 16yh Edition, 1989, F.A. Company, Philadelphia, PA. Thrasher, J.D.; Broughton, A., The Truth About The Indoor Formaldehyde Crisis: The Poisoning of Our Homes and Workplaces, 1989, Ceadora, Inc., Publisher, Santa Ana. CA. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease control, National Institute for Occupational Safety and Health, "NIOSH Pocket Guide to Chemical Hazards," June 1990, U.S. Government Printing Office, Washington, D.C. U.S. Department of Health and Human Services, Public Health Services, Centers for Disease Control, National Institute for Occupational Safety and Health, Division of Standards Development and Technology Transfer, "Occupational Safety and Health Guidelines for Chemical Hazards," 1988, U.S. Government Printing Office Washington, D.C. Publication No. 89-104. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, "NIOSH Current Intelligence bulletin 34 - Formaldehyde: Evidence of Carcinogenicity," April 15, 1981. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, "Regulations, Recommendations and Assessments Extracted from RTECS: A Subfile of the Registry of Toxic Effects of Chemical Substances," September 1986, U.S. Government Printing Office. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, "NIOSH Current Intelligence Bulletin 54 - Environmental Tobacco Smoke in Workplace: Lung Cancer and Other Health Effects," June 1991, U.S. Government Printing Office, Washington, DC. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, "NIOSH Current Intelligence bulletin 50 - Carcinogenic Effects of Exposure to Diesel Exhaust," August 1988, U.S. Government Printing Office, Washinton, DC. U.S. Environmental Protection Agency, Air and Radiation, Research and Development, "Indoor Air Facts No. 4 (revised), Sick Building Syndrome," April 1991. 26. Ethylene Oxide: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, "NIOSH Pocket Guide to Chemical Hazards," June 1990, U.S. Government Printing Office, Washington, D.C. U.S. Department of Health and Human Services, Public Health Services, Centers for Disease control, National Institute for Occupational Safety and Health, Division of Standards Development and Technology Transfer, "Occupational Safety and Health Guidelines for Chemical Hazards," 1988, U.S. government Printing Office, Washington, D.C., Publication No. 88-118. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease control, National Institute for Occupational Safety and Health, "NIOSH Current Intelligence bulletin 35 - Ethylene Oxide (EtO)," May 22, 1981. U.S. Department of Health and Human services, Public Health Service, ?agency for toxic Substances and Disease Registry, "Toxicology Profile for Ethylene Oxide," December 1990, Life Systems, Inc. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease control, National Institute for Occupational Safety and Health "Regulations, Recommendations and Assessments Extracted from RTECS: A Subfile of the Registry of Toxic Effects of Chemical Substances," September 1986, U.S. Government Printing Office. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease control, National Institute for Occupational Safety and Health, "NIOSH Current Intelligence Bulletin 52 - Ethylene Oxide Sterilizers in Health Care Facilities: Engineering Controls and Work Practices," July 13, 1989, U.S. government Printing Office, Washington, DC. U.S. Department of Health and Human Services, Public Health Service, Center for Disease Control, National Institute for Occupational Safety and Health, "Proposed National Strategies for the Prevention of Leading Work-Related Disease and Injuries: Neurotoxic Disorders," 1988, Government Printing Office, Washington, DC. U.S. Environmental Protection Agency, Air Quality Planning and Substances, "NATICH Data Base Report On State, Local, and EPA Air Toxics Activities," July 1990. U.S. General Accounting Office, "Reproductive and Developmental Toxicants: Regulatory Actions Provide Uncertain Protection," October 1991. (GAO/PEMD-92-3) 27. Carbon Black: Committee on Neurotoxicology and Models of Assessing Risk, Board on Environmental Studies and Toxicology, commission of Life Sciences, National Research council, Environmental Neurotoxicity, 1992, National academy Press, Washington, DC. National Library of Medicine's Toxicology Information Program, Agency for Toxic Substances and Disease Registry, Hazardous Substances Data Bank, "Methyl Isobutyl Ketone," as of January 18, 1992. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, "NIOSH Pocket Guide to Chemical Hazards," June 1990, U.S. Government Printing Office, Washington, D.C. U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, "Toxicology Profile for Total Xylenes," December 1990, Clement Associates, Inc. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease control, National Institute for Occupational Safety and Health, "NIOSH Current Intelligence bulletin 48 - Organic Solvent Neurotoxicity," March 31, 1987. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease control, National Institute for Occupational Safety and health, "Regulations, Recommendations and Assessments Extracted from RTECS: A Subfile of the Registry of Toxic Effects of Chemical Substances," September 1986, U.S. Government Printing Office. U.S. Environmental Protection Agency, Air Quality Planning and Substances, "NATICH Data Base Report On State, Local, and EPA Air Toxics Activities," July 1990. U.S. Environmental Protection Agency, Office of Toxic Substances, Economic and Technology Division, "Toxics in the community, National and Local Perspectives, The 1989 Toxics Reldease Inventory National Report," September 1991, Government Printing Office. 29. Hexone: National Library of Medicine's Toxicology Information Program, Agency for Toxic Substances and Disease Registry, Hazardous Substances Data Bank, "Methyl Isobutyl Ketone,: as of January 18, 1992. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease control, National Institute for Occupational Safety and Health, "NIOSH Pocket Guide to Chemical Hazards," June 1990, U.S. Government Printing Office, Washington, D.C. U.S. Department of Health and Human Services, Public Health Services, Centers for Disease Control, National Institute for Occupational Safety and Health, Division of Standards Development and Technology Transfer, "Occupational Safety and Health Guidelines for Chemical Hazards," 1988, U.S. government Printing Office Washington, D.C., Publication No. 89-104. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease control, National Institute for Occupational Safety and Health, "NIOSH Current Intelligence Bulletin 48 - Organic Solvent Neurotoxicity," March 31, 1987. U.S. Department of Health and Human services, Public Health Service, Centers for Disease control, National Institute for Occupational Safety and health, "Regulations, recommendations and assessments Extracted from RTECS: A Subfile of the Registry of Toxic Effects of Chemical Substances,: September 1986, U. S. government Printing Office. U.S. Environmental Protection Agency, Office of Toxic Substances, Economic and Technology Division, "Toxics in the community, National and Local Perspectives, The 1989 Toxics Release Inventory National Report," September 1991. government Printing Office. 34. Zinc Oxide: National Library of Medicine's Toxicology Information Program, Agency for toxic Substances and Disease Registry, Hazardous Substances Data Bank, "Zinc Oxide," as of January 24, 1992. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease control, National Institute for Occupational Safety and Health, "NIOSH Pocket Guide to Chemical Hazards," June 1990, U.S. government Printing Office, Washington, D.C. U.S. Department of Health and Human services, Public Health Service, Centers for Disease control, National Institute for Occupational Safety and Health, "Regulations, Recommendations and Assessments Extracted from RTECS: A Subfile of the Registry of Toxic Effects of Chemical Substances," September 1986, U.S. Government Printing Office. 35. Naptha: National Library of Medicine's Toxicology Information Program, Agency for Toxic Substances Data Bank, "Naptha," as of January 19, 1992. Sax, N.; Sewis, R.J., "Hazardous Chemicals Desk Reference," 1987, Van Norstand Rhienhold, New York. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control. National Institute for Occupational Safety and Health, "NIOSH Pocket guide to Chemical Hazards,: June 1990, U.S. government Printing Office, Washington, D.C. U.S. Department of health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, "NIOSH Current Intelligence bulletin 48 - Organic Solvent Neurotoxicity,: March 31, 1987. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, "Regulations, Recommendations and Assessments Extracted from RTECS: A subfile of the Registry of Toxic Effects of Chemical Substances,: September 1986, U.S. Government Printing Office. 36. Phenol: National Library of Medicine's Toxicology Information Program, Agency for Toxic Substances and Disease Registry, Hazardous Substances Data Bank, "Phenol," as of January 22, 1992. New York Department of Law: Abrams, Attorney General, "The Secret Hazards Of Pesticides," June 1991. , C.L., Editor "Taber's Cyclopedic Medical Dictionary, 16th Edition, 1989, F.A. company, Philadelphia, PA. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, "NIOSH Pocket guide to Chemical Hazards," June 1990, U.S. Government Printing Office, Washington, D.C. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, "Regulations, Recommendations and Assessments Extracted from RTECS: A Subfile of the Registry of Toxic Effects of Chemical Substances," September 1986, U.S. Government Printing Office. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, "NIOSH Current Intelligence bulletin 54 - Environmental Tobacco Smoke in the Workplace: Lung Cancer and Other Health Effects." June 1991, U.S. Government Printing Office, Washington, DC. U.S. Department of Health and Human Services, Public Health Service, Center for Disease Control, National Institute for Occupational Safety and Health, "Proposed National Strategies for the Prevention of Leading Work-Related Disease and Injuries: Neurotoxic Disorders," 1988, government Printing Office, Washington, D.C. U.S. Environmental Protection Agency, Air Quality Planning and Substances, "NATICH Data Base Report On State, Local, and EPA Air Toxics Activities," July 1990 37. Benzene: Committee on Neurotoxicology and Models of Assessing Risk, board on Environmental Studies and Toxicology, commission of Life Sciences, National Research Council, "Environmental Neurotoxicity," 1992, National Academy Press, Washington, D.C. National Library of Medicine's Toxicology Information Program, Agency for Toxic Substances and Disease Registry Hazardous Substances Data Bank, "Benzene," as of January 14, 1992. U.S. Department of Health and Human Services, Public Health service, Centers for Disease Control, National Institute for Occupational Safety and health, "NIOSH Pocket guide to Chemical Hazards," June 1990, U.S. government Printing Office, Washington, D.C. U.S. Department of Health and Human Services, Public Health Services, Centers for Disease Control, National Institute for Occupational Safety and Health, Division of Standards, Development and Technology Transfer, "Occupational Safety and Health Guidelines for Chemical Hazards," 1988, U.S. government Printing Office, Washington, D.C., Publication No. 89-104. U.S. Department of Health and Human services, Public Health service, Agency for Toxic Substances and Disease Registry, "Draft for Public comment" toxicology Profile for benzene," October 1991, Clement Associates, Inc. U.S. Department of Health and Human ?services, Public Health Service, Centers for Disease control, National Institute for Occupational Safety and Health, "NIOSH Current Intelligence Bulletin 48 - Organic Solvent Neurotoxicity," March 31, 1987. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, "Regulations, Recommendations and Assessments Extracted from RTECS: A Subfile of the Registry of Toxic Effects of Chemical Substances," September 1986, U.S. Government Printing Office. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease control, National Institute for Occupational Safety and Health, "NIOSH current Intelligence bulletin 54 - Environmental tobacco Smoke in the Workplace: Lung Cancer and Other Health Effects," June 1991, U.S. government Printing Office, Washington, D.C. U.S. Department of Health and Human Services, Public Health Service, Center for Disease Control, National Institute for Occupational Safety and Health, "Proposed National Strategies for the Prevention of Leading Work-Related Disease and Injuries: Neurotoxic Disorders," 1988, Government Printing Office, Washington, D.C. U.S. Environmental Protection Agency, Air Quality Planning and Substances, "NATICH Data Base Report On State, Local, and EPA Air Toxics Activities," July 1990. U.S. Environmental Protection Agency, Office of Toxic Substances, Economic and Technology Division, "Toxics in the community, National and Local Perspectives, The 1989 Toxics Release Inventory National Report," September 1991, government Printing Office. THE END Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.